Adis Journal Podcasts

Adis

Subscribe in Parasocial

Free on the App Store for iPhone, iPad and Mac. No subscription needed. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.

About

Listen to podcasts with key opinion leaders in multiple therapy areas, discussing hot topics including topic overviews, expert opinions and conference overviews. Brought to you by the Adis Journals Group, part of Springer Nature. The primary audience for these podcasts are healthcare professionals, and are published and citable through the journals.

Also on

Recent episodes

  • Dengue Vodcast: Insights from Recent Infectious Disease CongressesOct 30, 2026 · 37 min
  • A Podcast on Osimertinib After CRT in Unresectable Stage III EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC)Oct 13, 2026 · 34 min
  • Perspectives on 10 years of Immune Checkpoint Inhibitors in Merkel Cell Carcinoma: A PodcastOct 7, 2026 · 35 min
  • Management of Adverse Events Associated with MET TKIs in Patients with Advanced NSCLC: A Podcast DiscussionSep 12, 2026 · 44 min
  • Risk of Recurrence in Patients with HR+/HER2− Early Breast Cancer: A PodcastAug 31, 2026 · 37 min
  • Expert Perspectives on TGCT & the Outcomes of the Phase 3 MANEUVER Study of Pimicotinib Presented at ASCO and ESMO 2025Aug 24, 2026 · 45 min
  • Four-Year Outcomes of Faricimab in Diabetic Macular Edema in the RHONE-X Extension Trial: A PodcastAug 21, 2026 · 26 min
  • Vodcast on Real-World Comparative OS and PFS of CDK4/6 Inhibitors Plus an AI in the P-VERIFY StudyAug 6, 2026 · 18 min
  • Subcutaneous Amivantamab and Lazertinib in PALOMA-3: Efficacy, Safety, and Administration: A VodcastAug 6, 2026 · 12 min
  • Revolutionizing 2L+ Myeloma: A Podcast on the New Era of BCMA-Targeted Bispecific Antibody TherapiesJul 31, 2026 · 33 min

Website · RSS feed

Adis Journal Podcasts | Parasocial